2024-06-30 12:59:39 pm | Source: Sushil Financial
BUY VENUS REMEDIES LTD. For Target Rs. 388 - Sushil Financial
We had re-instated coverage on Venus Remedies Ltd. with a BUY rating on March 28, 2024 at Rs.310 for a target price of Rs.388 With the recent run-up in the share price, we change the rating to neutral and close our coverage on the company. At the day’s high of Rs.384, the stock has generated ~24% returns from our recommendation.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
India came through global disruptions solidly: EAM J...
Dalal Street enters consolidation phase amid high vo...
Karisma Kapoor reveals fun facts about mother Babita...
India significantly boosts placements, entrepreneurs...
"?koda Cars: Where European Engineering Meets Everyd...
FTA with EU likely to boost India`s competitiveness ...
Realme Narzo 20: A Budget Powerhouse That Redefined ...
No address proof needed for 5 Kg LPG cylinders: Gove...
Yoga Poses That Relieve Period Pain and Stress
Indian Railways to lay 1,929 km optical fibre cable ...
